Aim & Scope
Vaccines remain among the most effective health interventions ever developed, and understanding how the immune system goes wrong is central to much of modern medicine. The Journal of Vaccines and Immunopathology (JVI) publishes research on both.
We welcome work from the laboratory to the vaccination programme, and particularly studies that inform how vaccines are developed, deployed and trusted.
Scope
JVI publishes original research articles, review articles, case reports and short communications in areas including, but not limited to:
- Vaccine development, efficacy and effectiveness
- Vaccine safety and pharmacovigilance
- Immunisation programmes, coverage and hesitancy
- Adjuvants and delivery platforms
- Immune responses to infection
- Autoimmune and inflammatory disease
- Allergy and hypersensitivity
- Immunodeficiency
- Transplant immunology
- Immunotherapy and immunomodulation
Peer Review
Every submission goes through double-blind peer review by at least two independent reviewers with expertise in the subject. The usual time from submission to first editorial decision is 12–14 weeks. See the Peer Review Policy for details.
Originality
All manuscripts are screened for similarity with iThenticate before they go to reviewers, as set out in the Plagiarism Policy.
Open Access and Licensing
JVI is fully open access. Authors keep the copyright in their work, which is published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
There is no Article Processing Charge. Journal of Vaccines and Immunopathology charges authors nothing at any stage of submission, peer review or publication.
